Your browser doesn't support javascript.
loading
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
Shimizu, Toshio; Nakajima, Takako Eguchi; Yamamoto, Noboru; Yonemori, Kan; Koyama, Takafumi; Kondo, Shunsuke; Sunakawa, Yu; Izawa, Naoki; Horie, Yoshiki; Xiang, Silong; Xu, Siying; Qin, Lan; Gong, John; Liu, David.
Afiliação
  • Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 1040045, Japan. sentants@wakayama-med.ac.jp.
  • Nakajima TE; Department of Pulmonary Medicine and Medical Oncology, Graduate School of Medicine, Wakayama Medical University, Wakayama, 6418509, Japan. sentants@wakayama-med.ac.jp.
  • Yamamoto N; Department of Medical Oncology, St. Marianna University Hospital, Kawasaki, 2168511, Japan.
  • Yonemori K; Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, 6068507, Japan.
  • Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 1040045, Japan.
  • Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 1040045, Japan.
  • Sunakawa Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 1040045, Japan.
  • Izawa N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 1040045, Japan.
  • Horie Y; Department of Medical Oncology, St. Marianna University Hospital, Kawasaki, 2168511, Japan.
  • Xiang S; Department of Medical Oncology, St. Marianna University Hospital, Kawasaki, 2168511, Japan.
  • Xu S; Department of Medical Oncology, St. Marianna University Hospital, Kawasaki, 2168511, Japan.
  • Qin L; 3D Medicines Co., Ltd, Sichuan, China.
  • Gong J; 3D Medicines Co., Ltd, Sichuan, China.
  • Liu D; 3D Medicines Co., Ltd, Sichuan, China.
Invest New Drugs ; 40(5): 1021-1031, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35932387
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão